A Life of Science and Dreams: Amanda Feilding in conversation with David Luke.

Amanda Feilding is the Founder and Executive Director of the Beckley Foundation, a UK-based think-tank and NGO, founded in 1998. With more than 50 years of experience pioneering global drug policy reform and scientific research in consciousness and psychoactive substances, Amanda is widely recognised as the ‘Hidden Hand’ behind the Psychedelic Renaissance.

Amanda has personally co-authored over 80 peer-reviewed scientific publications on psychoactive substances, many with ground-breaking results, such as the world’s first LSD brain-imaging study, and the first clinical trial into psilocybin-assisted psychotherapy for treatment-resistant depression, which had remarkably beneficial results. To honour her contributions to science, she recently received the Science Pioneer Award at the WEDO awards ceremony held at the United Nations.

Called the ‘Queen of Psychedelics’ by the Economist Magazine, Amanda’s contribution has been pivotal in bridging the gap between science and policy, with the aim of building and harnessing our knowledge of the benefits of currently prohibited compounds to optimise human health, wellbeing and potential.